Eli lilly – Patient Worthy

Momentum Builds Across Biotech Pipeline: Seizure Breakthrough, Cell Therapy Revival, and Obesity Medicine Gains

Post author:Bree Clare
Post published:March 17, 2026
Post category:Seizures

The biotechnology sector experienced significant positive developments this week, with Xenon Pharmaceuticals' seizure medication achieving a decisive late-stage victory while regulatory pathways accelerated for several other promising therapies. According to…

Monthly Obesity Treatment Gets Easier: Lilly’s New Zepbound Pen Simplifies Weight Loss Injections

Post author:Bree Clare
Post published:March 3, 2026
Post category:Obesity

Patients using Zepbound for weight management now have a simpler option for administering their medication. As reported by PharmaLive.com, Eli Lilly received FDA clearance for a redesigned injection pen that…

Dual Approach to Disease: Eli Lilly’s Zepbound-Taltz Combination Demonstrates Breakthrough Results in Psoriasis Treatment

Post author:Bree Clare
Post published:February 27, 2026
Post category:Psoriasis

Eli Lilly is making strategic moves to expand its obesity medication Zepbound beyond weight management, demonstrating promising results when combined with its autoimmune therapeutic Taltz for treating patients with both…

Eli Lilly’s Jaypirca Positions Itself as Superior Alternative to Imbruvica in Blood Cancer Treatment

Post author:Bree Clare
Post published:December 21, 2025
Post category:Cancer

Eli Lilly presented compelling clinical evidence positioning its BTK inhibitor Jaypirca as a potentially superior treatment option compared to the established blood cancer therapy Imbruvica, marking a significant competitive shift…

Momentum Builds Across Biotech Pipeline: Seizure Breakthrough, Cell Therapy Revival, and Obesity Medicine Gains

Monthly Obesity Treatment Gets Easier: Lilly’s New Zepbound Pen Simplifies Weight Loss Injections

Dual Approach to Disease: Eli Lilly’s Zepbound-Taltz Combination Demonstrates Breakthrough Results in Psoriasis Treatment

Eli Lilly’s Jaypirca Positions Itself as Superior Alternative to Imbruvica in Blood Cancer Treatment

Let’s Work Together!

Keep Up to Date

Learn More